Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: Cancer. 2021 Nov 2;127(24):4546–4556. doi: 10.1002/cncr.33992

Figure 3.

Figure 3.

Percentages of treatment intolerability outcomes by AE trajectory groups. The 4 clusters of bar graphs from left to right indicate the incidence rate of AEs per cycle, drug modification in any cycle, early treatment discontinuation due to any reason, and discontinuation due to an AE. **P < .01, and ***P < .001 for all pairwise comparisons with the Low AE Traj group. AE indicates adverse event; Discont, discontinuation.